financetom
Business
financetom
/
Business
/
Chinese firms to suspend fertiliser exports: Report
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Chinese firms to suspend fertiliser exports: Report
Jul 30, 2021 3:52 AM

Some key Chinese firms have suspended fertiliser exports from the country in what looks like a temporary ban. The idea behind the move is to address the higher raw material prices, higher fertiliser prices, and ensure there is enough domestic availability.

China's National Development and Reform Commission (NDRC) said it had summoned fertiliser firms for a discussion against hoarding and speculation, though it did not mention the names of the companies.

The move is the latest by Beijing to tackle the soaring prices of major raw materials.

Fertiliser prices in China, have hit record highs this year amid strong overseas demand, lower current domestic production and high energy costs. China is both a major consumer and producer of fertilisers. In fact, India depends highly on China for urea imports.

Looking at the data that has come in from the fertiliser ministry’s annual report, India imports around 25 percent of its urea consumption; 90 percent of phosphates that are DAF fertilisers, and 100 percent of Potash. Out of these, around 30-35 percent of imports come in from China.

Urea futures prices on China's Zhengzhou Commodity Exchange have surged by over a third since the start of the year. They hit record highs of 2,616 yuan per tonne on Thursday but eased 2.7 percent on Friday.

Spot urea prices also soared to 2,814 yuan in early July, according to China's National Bureau of Statistics, up from 2,674 yuan a month ago.

NDRC's action follows comments from Premier Li Keqiang last month that drew attention to how high prices of key farm inputs are a potential threat to the country's food security.

It said on Friday it had urged key fertiliser companies to "operate in an orderly manner and not hoard, drive up prices, or fabricate or spread information about price increases."

Watch the accompanying video of CNBC-TV18’s Sonal Bhutra for more details.

-- With inputs from Reuters

(Edited by : Dipika)

First Published:Jul 30, 2021 12:52 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: AT&T Acquires Select Spectrum Assets from United States Cellular for $1.02 Billion
Update: AT&T Acquires Select Spectrum Assets from United States Cellular for $1.02 Billion
Nov 7, 2024
08:59 AM EST, 11/07/2024 (MT Newswires) -- (Update with AT&T's ( T ) response to a request for comment.) United States Cellular ( USM ) said Thursday it has entered into an agreement with AT&T ( T ) to sell a portion of its retained spectrum licenses for $1.02 billion. Substantially all of the deal is contingent upon the closing...
Audi unveils new EV brand in China without four ring logo
Audi unveils new EV brand in China without four ring logo
Nov 7, 2024
SHANGHAI, Nov 7 (Reuters) - Audi on Thursday unveiled a new electric vehicle brand in China whose cars will sport just the name AUDI and not its signature four-ring logo, a move aimed at attracting younger customers in the world's largest auto market. The premium marque owned by Germany's Volkswagen partnered with Chinese automaker SAIC last year to co-develop cars...
Tree Island Steel to Buy Back Up to 1.3 Million Shares
Tree Island Steel to Buy Back Up to 1.3 Million Shares
Nov 7, 2024
08:34 AM EST, 11/07/2024 (MT Newswires) -- Tree Island Steel ( TWIRF ) received Toronto Stock Exchange approval to renew its normal course issuer bid and can buy back up to 1.3 million shares for a year beginning on Nov. 11. Under its current buyback program, which expires on Nov. 8, Tree Island Steel ( TWIRF ) acquired 1.15 million...
Xanax maker Viatris beats quarterly estimates on demand for new generic drugs
Xanax maker Viatris beats quarterly estimates on demand for new generic drugs
Nov 7, 2024
Nov 7 (Reuters) - Drugmaker Viatris beat Wall Street estimates for third-quarter profit and revenue on Thursday, helped by strong demand for its new generic asthma and ADHD drugs, among others, sending its shares up 2.5% premarket. Sales at Viatris' ( VTRS ) generic business have been boosted by new products such as Breyna, a cheaper version of AstraZeneca's (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved